-
ISPOR Student Webinar: Health Economic Analyses and Modelling using R
Jul 6, 2021, 10:36 AM -
Pathways to ISPOR Leadership – Bertalan Nemeth
Jul 6, 2021, 10:03 AM -
Real World Oncology in China: Unique Opportunities to Drive Improved Patient Access and Outcomes
Jun 29, 2021, 19:15 PM -
Implications of Matched Adjusted Indirect Treatment Comparisons in Rare Disease
Jun 7, 2021, 10:29 AM -
El futuro digital de la salud
May 14, 2021, 16:33 PM -
The Power of Human+Digital Connection
May 12, 2021, 08:58 AM -
Generando inversiones para la atención en salud en América Latina
Apr 12, 2021, 15:31 PM -
ISPOR's New Science Strategy - A Member-Generated Roadmap of HEOR Priorities and Frontiers
Mar 23, 2021, 12:37 PM -
The Impact of COVID-19 in Healthcare: Challenges and Opportunities in Latin America
Mar 17, 2021, 12:30 PM -
Esquemas de Acuerdo Administrado/Managed Entry Agreements (MEAs)
Mar 9, 2021, 18:19 PM -
Challenges in Assessing the Clinical and Economic Value of Future Treatments for Alzheimer’s Disease
Feb 26, 2021, 17:42 PM -
Reimbursement Models and Value-Assessment Approaches in the Digital Health Ecosystem – Asia Pacific Perspectives
Feb 23, 2021, 15:57 PM -
Supporting Covid19-Related Decision Making with Health Preference Research
Feb 17, 2021, 00:59 AM -
Biosimilars: Market Access Challenges & Opportunities Worldwide
Feb 4, 2021, 12:36 PM -
Pathways to ISPOR Leadership - Mike Drummond
Jan 26, 2021, 15:00 PM -
Shaking the Myth of Real World Evidence: Updates From the RWE Transparency Initiative
Dec 17, 2020, 13:18 PM -
The 4th Industrial Revolution, Digital Transformation and Patient Centricity: A Leadership View
Dec 15, 2020, 11:04 AM -
CHEERS II: Bold Directions for New Reporting Standards?
Dec 4, 2020, 17:53 PM -
The Proper Order of Things is Often a Mystery: A Novel Approach to Selecting Treatment Sequences
Dec 3, 2020, 14:29 PM -
Long Term Value Demonstration in Alzheimer’s Disease: Evidence Needs
Dec 1, 2020, 11:39 AM